Compare RAPP & SVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAPP | SVC |
|---|---|---|
| Founded | 2022 | 1995 |
| Country | United States | United States |
| Employees | N/A | 1000 |
| Industry | | Real Estate Investment Trusts |
| Sector | | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.1B |
| IPO Year | 2024 | 1995 |
| Metric | RAPP | SVC |
|---|---|---|
| Price | $40.21 | $8.76 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 6 | 3 |
| Target Price | ★ $48.50 | $2.50 |
| AVG Volume (30 Days) | 436.6K | ★ 8.0M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.67% |
| EPS Growth | 24.34 | ★ 26.95 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,814,838,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.39 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.64 | $1.13 |
| 52 Week High | $43.76 | $9.02 |
| Indicator | RAPP | SVC |
|---|---|---|
| Relative Strength Index (RSI) | 53.67 | 89.71 |
| Support Level | $33.54 | $1.69 |
| Resistance Level | $43.70 | $9.02 |
| Average True Range (ATR) | 2.93 | 0.25 |
| MACD | -0.03 | 0.33 |
| Stochastic Oscillator | 40.17 | 96.27 |
Rapport Therapeutics Inc is a clinical-stage biotechnology company dedicated to the discovery and development of small-molecule precision medicines for patients with neurological or psychiatric disorders. The company's portfolio of programs from its RAP technology platform includes RAP-219, an investigational small molecule being developed as a therapy for focal onset seizures, primary generalized tonic-clonic seizures, and bipolar mania. Additionally, it has two discovery-stage nicotinic acetylcholine receptor (nAChR) programs stemming from its RAP technology platform: one being developed for the treatment of chronic pain, and the second, being developed for the treatment of hearing disorders. Geographically, the company operates in the United States.
Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its segments hotel investment unit, and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza, Hyatt Place, and others.